Clin2
NCT06851663Likely a fitRecruiting

New PET scan for many solid tumors

Solid TumorSolid CarcinomaUroepithelial CarcinomaBladder CancerProstate CancerLung CancerNasopharyngeal CancerLiver Cancer

Treatments studied

Part of Cancer, Digestive system, Ear, nose & throat, Hormones & metabolism, Kidney & urinary, Lungs & breathing, Mouth & dental, Women’s health & pregnancy clinical trials.

This trial tests a new type of PET scan that uses a special antibody to find a marker called Trop2 on many common solid tumors. It may help doctors see tumors more clearly without needing a biopsy.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
400 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • You have been diagnosed with or are suspected of having one of these cancers: bladder, prostate, lung, liver, ovarian, cervical, or others listed.
  • You are not pregnant.
  • You do not have severe liver or kidney problems.
  • You are not allergic to antibody-based imaging agents used in scans.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07639801Not yet recruiting
New PET scan for diagnosing solid tumors

This study is testing a new type of PET scan that uses a special tracer to make tumors easier to see. It may help doctors get more accurate information about your tumor before you have a biopsy or surgery.

NCT07046702Recruiting
PET scan using a new tracer for solid tumors

This study tests whether a new imaging agent called 68Ga-MY6349 can help detect tumors during a PET/CT scan. If you are an adult with a solid tumor (newly diagnosed or already treated), you may be able to take part in this research to see if the new tracer works better than standard imaging.

Xiamen, Fujian
NCT06696326Recruiting
New PET scan for prostate cancer detection

This study tests a new type of PET/CT scan that uses a special tracer (68Ga-MY6349) to better see prostate cancer in the body. It may help doctors find cancer that has come back or spread, so you can get the right treatment sooner.

Xiamen, Fujian
NCT06720298Not yet recruiting
New imaging agent for PET scans in cancer

This study tests a new imaging agent that helps PET scans show cancer more clearly. It may help doctors see where cancer is in your body and plan your treatment better.

Beijing, Beijing Municipality
NCT07760012Recruiting
Pet scan with new tracer for solid tumors

This study uses a new imaging tracer, called 68Ga-SorB, during a PET/CT scan to look at tumors. It may help doctors see cancer more clearly. The trial is for adults with certain types of solid tumors (such as melanoma, liver, lung, breast, pancreatic, ovarian, or bile duct cancer) who need a PET/CT scan as part of their care.

Beijing, Beijing Municipality
NCT06719856Recruiting
PET imaging study for multiple solid tumors

This trial uses a special PET scan to take pictures of certain solid tumors. The scan uses a new dye that may help doctors see the tumors more clearly. You may be eligible if you have one of the listed cancers and are between 18 and 75 years old with good daily function.

Beijing, Beijing Municipality

Hear when a new Solid Tumor trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.